Latigo Biotherapeutics, Inc. (LTGO)

21.08 -1.47 (-6.52%) USD  |  NASDAQ  |  Sep 21, 16:00
20.70 -0.38 (-1.80%) After-Hours: 20:00
More

Latigo Biotherapeutics Shareholders Equity (Quarterly) : 12.50M for June 30, 2026

Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for LTGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 12.50M
Date Value
March 31, 2026 36.00M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M
Johnson & Johnson 84.97B
Eli Lilly & Co. 33.88B

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 64.76M
Total Liabilities (Quarterly) 52.26M
Debt to Equity Ratio 2.500
Current Ratio 1.148